Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Primary reporting period: 2026-06-30 · Research updated Oct 13, 2026. A research update is not a new financial filing.
Who they are
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements.
How they make money
Natural Alternatives International, Inc. generates revenue primarily through contract manufacturing services for nutritional supplement companies, providing formulation, clinical research, and regulatory support. Additionally, the company markets and sells its own branded nutritional products, including those utilizing its proprietary ingredients, to various distribution channels.
Products & services
Nutritional supplement contract manufacturing, custom product formulation, clinical studies, regulatory compliance support, and branded products featuring proprietary ingredients like CarnoSyn, SR CarnoSyn, and TriBsyn.
Brands & revenue mix
CarnoSyn
Proprietary beta-alanine ingredient used in sports nutrition and healthy aging products.
Separate brand revenue is not available in this research.Source
SR CarnoSyn
Sustained-release version of the proprietary CarnoSyn ingredient.
Separate brand revenue is not available in this research.Source
TriBsyn
Proprietary ingredient offering for the nutritional supplement market.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
The company does not disclose specific customer concentration figures in its 2026 annual report, though it notes reliance on a limited number of significant customers for a substantial portion of its net sales.
Suppliers, materials & equipment
Raw material and ingredient suppliers — The company sources various raw materials and ingredients from multiple third-party suppliers to support its manufacturing operations.Source
Strengths
Proprietary ingredient portfolio including CarnoSyn and SR CarnoSynSource
Integrated contract manufacturing and formulation capabilitiesSource
Risks
Dependence on a limited number of significant customersSource
Regulatory risks associated with dietary supplement manufacturing and labelingSource
Overall investment score · Quality, value, risk and opportunity
21
Poor
PoorElite
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
17
Poor
Financial Strength
33
Business Quality / Moat
13
Management
0
Growth Quality
18
Risk / Durability
13
Weak Company · Expensive Stock
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
39
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
41/100
Building Historical Record
Model Score 41/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
What we like
•Insider activity signal is favorable
•Recent buyback activity is present
What to watch
•Elevated debt risk
•Valuation is a weaker part of the current profile
•Revenue fundamentals are weak
Company-specific research
Questions worth answering for NAII
Research inputs 100% complete
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
•Can NAII maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
•How long can NAII fund negative free cash flow using its current cash position before it may need more debt or new shares?
•Is NAII's debt load manageable relative to cash generation, interest costs and upcoming maturities?
•What specifically needs to improve for NAII to reach sustainable profitability?
•What future growth or profitability would be needed to justify NAII's current valuation?
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
Volatility = How violently is it moving?
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for NAII
Detected from reported data — verify before acting.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Elevated debt risk
Interest coverage is below 2x • Free cash flow is negative • Cash covers less than 20% of total debt
Community Sentiment
0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)
No personal call yet on NAII.
Potential upside factors
+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
+Proprietary ingredient portfolio including CarnoSyn and SR CarnoSyn.
+Integrated contract manufacturing and formulation capabilities.
Potential downside factors
−Debt risk (elevated): Interest coverage is below 2x.
−Free cash flow is negative.
−Cash covers less than 20% of total debt.
−Dependence on a limited number of significant customers.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdown
Wall Street Score
Very Weak21/ 100
Weak (0–50)Fair (51–71)Strong (72+)
Debt
Fair
50
Debt Cost2.4%
Debt Reduction YoY15.3%
Debt / Equity1.00x
Tap for breakdown →
Revenue
Poor
29
Revenue YoY0.0%
Revenue CAGR11.5%
Net Margin-14.6%
Tap for breakdown →
Asset
Fair
55
Asset Growth YoY-16.8%
Liquidation/Share$8.29
Net Assets/MCap9.45x
Tap for breakdown →
Capital
Poor
33
Earnings Yield-255.7%
Buyback Yield6.1%
Debt Cost2.4%
Tap for breakdown →
Management
Poor
0
ROIC-9.8%
ROE-41.4%
ROA-16.4%
Tap for breakdown →
Moat
Poor
13
EPS Growth—
FCF/Share Growth—
Rev/Share Growth1.2%
Tap for breakdown →
Valuation
Poor
0
Intrinsic Value—
Value Reference—
MOS—
Tap for breakdown →
Buffett
Poor
29
Revenue29
Moat13
Valuation0
Tap for breakdown →
MOS
Poor
0
MOS %—
Value Reference—
Deep Discount Reference—
Tap for breakdown →
Financial
Poor
19
Interest Coverage-7.6x
ROIC-9.8%
FCF Yield-155.9%
Tap for breakdown →
Master
Poor
15
Financial19
Valuation0
Debt50
Tap for breakdown →
Resilience
Poor
22
Survival Years0.6 yrs
Current Ratio1.73x
FCF Margin-8.9%
Tap for breakdown →
Was this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
YesNot yetDismiss
Score Changes
3 historical score records available
Previous Score
25
Oct 1, 2026
Change
-4.7
points
Current Score
21
Oct 8, 2026
Category Changes
Revenue0
Debt-42.3
Assets0
Capital0
Management0
Moat0
Valuation0
Buffett-10.6
NAII decreased 4.7 points because Debt declined by 42.3 points, Buffett declined by 10.6 points.
Negative Contributors
− Debt declined by 42.3 points
− Buffett declined by 10.6 points
Projected Score
Projected Score
24
Projected Change
+3.6 points
Preliminary comparable-period financial changes suggest improvement of approximately 3.6 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailable
Current Price
$1.13
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Value Reference: —
Deep Discount Reference: —
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Monetary values in USD. Share counts in raw units.
Income StatementBalance SheetCash Flow
AnnualQuarterlyTTM + Annual
All rows
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
Line Item
TTM
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
$141.4M
$141.4M
$129.9M
$113.8M
····
····
····
····
····
····
····
Cost of Revenue
$133.5M
$133.5M
$120.6M
$106.9M
····
····
····
····
····
····
····
Gross Profit
$7.8M
$7.8M
$9.3M
$6.9M
····
····
····
····
····
····
····
Research & Development
$1.8M
$2.3M
$1.8M
$1.9M
····
····
····
····
····
····
····
SG&A Expenses
$17.0M
$17.3M
$16.5M
$15.4M
····
····
····
····
····
····
····
Operating Expenses
$16.9M
$16.9M
$17.9M
$15.4M
····
····
····
····
····
····
····
EBITDA
-$4.2M
-$4.4M
-$2.7M
-$4.5M
····
····
····
····
····
····
····
Operating Income
-$9.1M
-$9.1M
-$8.7M
-$8.5M
····
····
····
····
····
····
····
Interest Expense
$1.2M
$1.2M
$915K
$361K
····
····
····
····
····
····
····
Income Before Tax
-$20.3M
-$20.3M
-$10.7M
-$9.5M
····
····
····
····
····
····
····
Income Tax Expense
$430K
$430K
$2.8M
-$2.2M
····
····
····
····
····
····
····
Net Income
-$20.7M
-$20.7M
-$13.6M
-$7.2M
····
····
····
····
····
····
····
Basic EPS
$-3.42
$-3.43
$-2.28
$-1.23
····
····
····
····
····
····
····
Basic Shares
6.07M
6.03M
5.95M
5.87M
····
····
····
····
····
····
····
Diluted Shares
6.07M
6.03M
5.95M
5.87M
····
····
····
····
····
····
····
Upgrade to Premium for up to 10 annual periods, where available.
Estimated earnings date:A future estimated earnings date is not currently available.
Jun 30, 2026Q4FY2025
Revenue
$34.2M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$2.23
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-15.3%
Cash Change
-40.1%
Margin Change
-18.3 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
Debt reduced
What Weakened
Margins contracted
Cash position declined
Potential Score Impact
Positive indicators included revenue growth, EPS growth, debt levels. Pressure indicators included cash levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 1.1%. EPS increased 90.6%. Cash declined 40.1%. Total debt declined 15.3%. Net income margin declined by 18.3 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Upgrade to Premium to unlock all earnings history.View plans
Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.
Dividend HistoryShare
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Predictions & Historical PerformanceShare
Conservative Projected Values
3 Years
$———.——
Premium
5 Years
$———.——
Premium
10 Years
$———.——
Premium
Conservative Projection Rate
——%
Premium
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.